Granted Patent B2

US 11,598,699 · App. 16/994,124 · Granted Mar 7, 2023

Inventors: Alan Marc Fine (Prospect, CA); Hershel Macaulay (Cambridge, MA)

Assignee: Alentic Microscience Inc.

G01N1/2813G01N1/38G01N21/31G01N33/49G02B21/0008G02B21/365G01N2001/386G01N2201/068G01N2201/12

Abstract

Claims (26)

1. A method comprising:

generating a diluted sample, wherein generating the diluted sample comprises mixing a sample of blood with one or more diluents;

forming a film of the diluted sample on a microscopy apparatus, the microscopy apparatus comprising a contact optical microscopy sensor comprising a pixel array underlying the film of the diluted sample;

illuminating red blood cells within a portion of the film of the diluted sample using light of a predetermined wavelength;

acquiring, by the contact optical microscopy sensor, one or more images of the diluted sample using the light of the predetermined wavelength after the light has transmitted through the diluted sample;

and

determining a mean corpuscular hemoglobin in the red blood cells within the portion of the film of the diluted sample based on (i) an intensity of the light of the predetermined wavelength sensed by a plurality of pixels of the pixel array and (ii) pixel sizes of the plurality of pixels.

2. The method of claim 1 , wherein forming the film comprises forming the film between a transparent lid and a surface of the microscopy apparatus.

3. The method of claim 2 , wherein forming the film between the transparent lid and the surface of the microscopy apparatus comprises:

placing the diluted sample on the surface of the microscopy apparatus; and

lowering the transparent lid to a predetermined height determined by a spacer.

4. The method of claim 3 , wherein a magnitude of the predetermined height is configured such that lowering of the transparent lid onto the surface (i) constrains the red blood cells within the portion of the film to lie within a broadest dimension of the red blood cells parallel to the surface, and (ii) does not result in structural damage to the red blood cells.

5. The method of claim 1 , wherein the one or more images of the diluted sample that are acquired include image features of at least one hundred red blood cells.

6. The method of claim 1 , wherein the predetermined wavelength comprises a wavelength that corresponds to a wavelength within an absorbance band of a form of hemoglobin with a highest extinction coefficient of the form of hemoglobin.

7. The method of claim 1 , wherein determining the mean corpuscular hemoglobin comprises:

estimating a background pixel value for each pixel of the plurality of pixels;

segmenting one or more regions within at least one of the one or more images, such that each region contains exactly one red blood cell; and

calculating the mean corpuscular hemoglobin based on the one or more regions.

8. The method of claim 1 , wherein the diluted sample:

has an isotonicity that is substantially equal to an isotonicity of red blood cells;

has coagulation properties such that the diluted sample is less likely to coagulate compared to coagulation properties of red blood cells; and

maintains a predetermined pH level of the diluted sample.

9. The method of claim 1 , wherein the one or more images include at least a statistically significant number of the red blood cells in the diluted sample.

10. The method of claim 1 , wherein at least one of the one or more diluents comprises a nitrite.

11. The method of claim 1 , wherein generating the diluted sample comprises generating the diluted sample based on mixing the sample of blood with the one or more diluents such that the mixing results in sphering of the red blood cells.

12. The method of claim 1 , wherein determining the mean corpuscular hemoglobin is based on a thickness of the film of the diluted sample.

Assignments (1)

Continuity (9)